277 related articles for article (PubMed ID: 16414376)
1. Examination of GyE system for HIMAC carbon therapy.
Kanai T; Matsufuji N; Miyamoto T; Mizoe J; Kamada T; Tsuji H; Kato H; Baba M; Tsujii H
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):650-6. PubMed ID: 16414376
[TBL] [Abstract][Full Text] [Related]
2. Comparison of biological effectiveness of carbon-ion beams in Japan and Germany.
Uzawa A; Ando K; Koike S; Furusawa Y; Matsumoto Y; Takai N; Hirayama R; Watanabe M; Scholz M; Elsässer T; Peschke P
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1545-51. PubMed ID: 19306751
[TBL] [Abstract][Full Text] [Related]
3. Mapping of RBE-weighted doses between HIMAC- and LEM-Based treatment planning systems for carbon ion therapy.
Steinsträter O; Grün R; Scholz U; Friedrich T; Durante M; Scholz M
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):854-60. PubMed ID: 22483698
[TBL] [Abstract][Full Text] [Related]
4. LET and ion-species dependence for cell killing and mutation induction in normal human fibroblasts.
Tsuruoka C; Suzuki M; Fujitaka K
Biol Sci Space; 2003 Oct; 17(3):185-6. PubMed ID: 14676365
[TBL] [Abstract][Full Text] [Related]
5. Test of the local effect model using clinical data: tumour control probability for lung tumours after treatment with carbon ion beams.
Scholz M; Matsufuji N; Kanai T
Radiat Prot Dosimetry; 2006; 122(1-4):478-9. PubMed ID: 17145727
[TBL] [Abstract][Full Text] [Related]
6. Direct comparison of biologically optimized spread-out bragg peaks for protons and carbon ions.
Wilkens JJ; Oelfke U
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):262-6. PubMed ID: 17935903
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy systems using proton and carbon beams.
Jongen Y
Bull Mem Acad R Med Belg; 2008; 163(10-12):471-8; discussion 479-80. PubMed ID: 20120253
[TBL] [Abstract][Full Text] [Related]
8. [Heavy ion therapy for non-small cell lung cancer].
Miyamoto T; Yamamoto N; Nishimura H; Tujii H; Yamaguchi Y
Nihon Geka Gakkai Zasshi; 1999 Nov; 100(11):729-34. PubMed ID: 10629839
[TBL] [Abstract][Full Text] [Related]
9. LET and ion-species dependence for mutation induction and mutation spectrum on hprt locus in normal human fibroblasts.
Tsuruoka C; Suzuki M; Fujitaka K
Biol Sci Space; 2004 Nov; 18(3):188-9. PubMed ID: 15858385
[TBL] [Abstract][Full Text] [Related]
10. Clinical ion beams: semi-analytical calculation of their quality.
Inaniwa T; Furukawa T; Matsufuji N; Kohno T; Sato S; Noda K; Kanai T
Phys Med Biol; 2007 Dec; 52(24):7261-79. PubMed ID: 18065838
[TBL] [Abstract][Full Text] [Related]
11. High relative biologic effectiveness of carbon ion radiation on induction of rat mammary carcinoma and its lack of H-ras and Tp53 mutations.
Imaoka T; Nishimura M; Kakinuma S; Hatano Y; Ohmachi Y; Yoshinaga S; Kawano A; Maekawa A; Shimada Y
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):194-203. PubMed ID: 17707273
[TBL] [Abstract][Full Text] [Related]
12. Radiobiology with heavy charged particles: a historical review.
Skarsgard LD
Phys Med; 1998 Jul; 14 Suppl 1():1-19. PubMed ID: 11542635
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of the local effect model for the prediction of biologic effects of carbon ion beams in vitro and in vivo.
Elsässer T; Krämer M; Scholz M
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):866-72. PubMed ID: 18430521
[TBL] [Abstract][Full Text] [Related]
14. Relative biological effectiveness for cell-killing effect on various human cell lines irradiated with heavy-ion medical accelerator in Chiba (HIMAC) carbon-ion beams.
Suzuki M; Kase Y; Yamaguchi H; Kanai T; Ando K
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):241-50. PubMed ID: 10924995
[TBL] [Abstract][Full Text] [Related]
15. [Present status of carbon ion radiotherapy for malignant tumors].
Sugahara S; Kamada T
Gan To Kagaku Ryoho; 2009 Nov; 36(11):1795-800. PubMed ID: 19920380
[TBL] [Abstract][Full Text] [Related]
16. Proton vs carbon ion beams in the definitive radiation treatment of cancer patients.
Suit H; DeLaney T; Goldberg S; Paganetti H; Clasie B; Gerweck L; Niemierko A; Hall E; Flanz J; Hallman J; Trofimov A
Radiother Oncol; 2010 Apr; 95(1):3-22. PubMed ID: 20185186
[TBL] [Abstract][Full Text] [Related]
17. Phase I/II clinical trials of carbon ion therapy for prostate cancer.
Akakura K; Tsujii H; Morita S; Tsuji H; Yagishita T; Isaka S; Ito H; Akaza H; Hata M; Fujime M; Harada M; Shimazaki J;
Prostate; 2004 Feb; 58(3):252-8. PubMed ID: 14743464
[TBL] [Abstract][Full Text] [Related]
18. [Heavy ion therapy for lung cancer].
Miyamoto T
Nihon Rinsho; 2002 May; 60 Suppl 5():424-8. PubMed ID: 12101706
[No Abstract] [Full Text] [Related]
19. In vitro interaction of high-LET heavy-ion irradiation and chemotherapeutic agents in two cell lines with different radiosensitivities and different p53 status.
Takahashi T; Fukawa T; Hirayama R; Yoshida Y; Musha A; Furusawa Y; Ando K; Nakano T
Anticancer Res; 2010 Jun; 30(6):1961-7. PubMed ID: 20651340
[TBL] [Abstract][Full Text] [Related]
20. A mechanism-based approach to predict the relative biological effectiveness of protons and carbon ions in radiation therapy.
Frese MC; Yu VK; Stewart RD; Carlson DJ
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):442-50. PubMed ID: 22099045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
